Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Flow Cytometry In Oncology And Immunology Market?
The flow cytometry in oncology and immunology market has experienced rapid expansion in recent years. Projections show it will increase from $2.11 billion in 2024 to $2.32 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.1%. This historical development can be primarily linked to advancements in cancer research, the expansion of immunology research, diverse diagnostic applications, a rise in autoimmune diseases, and progress in drug development and clinical trials.
The flow cytometry in oncology and immunology market size is projected to undergo significant expansion in the upcoming years. It is expected to achieve a valuation of “$3.45 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.4%. This anticipated growth can be attributed to several factors including the integration with genomics and proteomics, increasing adoption of single-cell analysis, wider applications in infectious diseases, a rise in cancer incidence, and the emergence of point-of-care flow cytometry. Significant developments foreseen in this period include immunophenotyping for immunotherapy, the miniaturization of flow cytometry systems, advancements in multiparametric analysis, a transition towards spectral flow cytometry, and increased collaborative research initiatives.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp
What Are The Key Drivers Of Growth In The Flow Cytometry In Oncology And Immunology Market?
The rising incidence of cancer is anticipated to fuel the expansion of flow cytometry within the oncology and immunology market moving ahead. Cancer refers to a collection of illnesses marked by the uncontrolled multiplication and dispersal of atypical cells throughout the body. In oncology and immunology, flow cytometry serves as a frequently employed method for examining cancer and immune cells. An illustration of this is the October 2022 report from Macmillan Cancer Support, a UK-based healthcare charity, which stated that 3 million people had cancer in 2020, with forecasts suggesting a climb to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the growing occurrence of cancer is a key factor propelling the advancement of flow cytometry in the oncology and immunology markets.
What Are The Key Segments In The Flow Cytometry In Oncology And Immunology Market?
The flow cytometry in oncology and immunologymarket covered in this report is segmented –
1) By Type: Immunology; Oncology
2) By Technology: Cell-Based Flow Cytometry; Bead-Based Flow Cytometry
3) By Application: Translational Research; Clinical Research
4) By End User: Hospitals; Diagnostic Laboratories; Reference Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling; Cytokine Detection; T-Cell And B-Cell Analysis; Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis; Tumor Microenvironment Studies; Minimal Residual Disease Detection; Biomarker Discovery And Validation
What Are The Latest Industry Trends Transforming The Flow Cytometry In Oncology And Immunology Market?
Technological advancements represent a significant trend emerging in flow cytometry within the oncology and immunology market. Major companies operating in flow cytometry across the oncology and immunology markets are adopting new technologies to secure their market position. As an illustration, in September 2022, Becton Dickinson, and Company, a US-based medical technology provider, unveiled BD Research Cloud for flow cytometry in oncology and immunology. BD Cloud is a cloud-based software system that streamlines the flow cytometry process for researchers engaged in fields such as immunology, virology, infectious disease, and oncology surveillance, enabling higher-quality studies with accelerated time to insight. BD is employing innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly launched BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, to enhance the functionalities of flow cytometry, allowing researchers to optimize and advance their pioneering studies. Built on an industry-standard cloud infrastructure, BD Research Cloud is specifically compatible with BD equipment and reagents.
Which Industry Leaders Are Driving Innovation Across The Flow Cytometry In Oncology And Immunology Market?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Flow Cytometry In Oncology And Immunology Market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Flow Cytometry In Oncology And Immunology Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp
Browse Through More Reports Similar to the Global Flow Cytometry In Oncology And Immunology Market 2025, By The Business Research Company
Flow Cytometry Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report
Immuno Oncology Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
Interventional Oncology Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model